Glenmark spin-out aims to challenge Amgen, others in cancer bispecific field

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 15, 2019 at 10:32 PM.

  1. #1 cafead, Oct 15, 2019 at 10:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via A new spin-out of an Indian company best known for making generic drugs aims to compete with top biotechs like Amgen and Regeneron in one of oncology's biggest research areas.

    article source
     
    Quote

Reply to Thread